Treatment of non-culprit lesions detected during primary PCI: Long-term follow-up of a randomised clinical trial

Netherlands Heart Journal

Volumn 20, Issue 9, 2012, Pages 347-353

  Ghani, A ^a   Dambrink, J H E ^a   van't Hof, A W J ^a   Ottervanger, J P ^a   Gosselink, A T M ^a   Hoorntje, J C A ^a  

^a Isala klinieken ^*  (Netherlands)

Author keywords

Acute myocardial infarction; Long term follow up; Medical therapy; Multi vessel disease; Multivessel angioplasty; Primary percutaneous coronaryintervention

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEATH; EXERCISE TEST; FEMALE; FOLLOW UP; FRACTIONAL FLOW RESERVE; HEART MUSCLE REVASCULARIZATION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE PROCEDURE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT;

EID: 84866244545     PISSN: 15685888     EISSN: 18766250     Source Type: Journal    
DOI: 10.1007/s12471-012-0281-y     Document Type: Article

References (14)

1. Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and Mediterranean basin. The Euro Heart survey of acute coronary syndromes. Eur Heart J. 2002;23:1190-201.
2. Sorajja P, Gersh BJ, Cox DA, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J. 2007;28:1709-16.
3. Goldstein JA, Demetriou D, Grines CL, et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med. 2000;343:915-22.
4. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European society of cardiology. Eur Heart J. 2003;24:28-66.
5. Politi L, Sgura F, Rossi R, et al. A randomized trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term followup. Heart. 2010;96:662-7.
6. Serruys PW, Unger F, van Hout BA, et al. The ARTS study (Arterial Revascularization Therapies Study). Semin Interv Cardiol. 1999;4:209-19.
7. Dambrink JHE, Debrauwere JP, van 't Hof AWJ, et al. Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines? EuroIntervention. 2010;5:968-75.
8. Hannan EL, Samadashvili Z, Walford G, et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv. 2010;3:22-31.
9. Di Mario C, Mara S, Flavio A, et al. Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study. Int J Cardiovasc Intervent. 2004;6:128-33.
10. Biondi-Zoccai G, Lotrionte M, Sheiban I. Management of multivessel coronary disease after ST-elevation myocardial infarction treated by primary coronary angioplasty [Review]. Am Heart J. 2010;160:S28-35.
11. Widimsky P, Holmes DR. How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease? Eur Heart J. 2011;32:396-403.
12. Vlaar PJ, Mahmoud KD, Holmes DR, et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2011;58:692-703.
13. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the european society of cardiology. Eur Heart J. 2005;26:804-47.
14. Van der Schaaf RJ, Vis MM, Sjauw KD, et al. Impact of multivessel coronary disease on long-term mortality in patients with STelevation myocardial infarction is due to the presence of a chronic total occlusion. Am J Cardiol. 2006;98:1165-9.